BridgeBio Pharma BBIO
NASDAQ BBIO
$67.55 -0.39 (-0.57%)
At close: Oct 20, 2026 · 4:00 PM EDT

BridgeBio Pharma (BBIO) Non-Current Assets (2018 - 2026)

Updated

BridgeBio Pharma (BBIO) reported Non-Current Assets of $124.16 million for Q2 2026, down 26.1% from $167.91 million a year earlier and down 4.3% from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Non-Current Assets (2018 - 2026) Analysis & Trends

At the end of FY2025, BridgeBio Pharma posted Non-Current Assets of $138.28 million, down 30.4% from FY2024.

  • Non-Current Assets has a five-year compound annual growth rate of 17.9% (FY2020 to FY2025).
  • By year, Non-Current Assets came in at $198.65 million in FY2024 (+188.8%), $68.79 million in FY2023 (-7.3%), $74.18 million in FY2022 (-40.1%) and $123.93 million in FY2021 (+104.0%).
  • The Q2 2026 figure ranks as the lowest quarterly Non-Current Assets since Q1 2024.
  • Year over year, Non-Current Assets has now declined in each of the last five quarters, with growth averaging 59.8% over the last eight quarters.
  • The high point for year-over-year Non-Current Assets in five years was Q3 2021 (growth of 235.2%); the low point was Q2 2022 (a decline of 47.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $129.68 million (Q1 2026), $138.28 million (Q4 2025) and $158.87 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 141.29 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 101.45 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 87.87 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 35.42 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 159.77 Bn
10 BridgeBio Pharma 13.20 Bn 10.31 Bn 228.63 Mn 124.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 124.16 Mn
Mar 31, 2026 129.68 Mn
Dec 31, 2025 138.28 Mn
Sep 30, 2025 158.87 Mn
Jun 30, 2025 167.91 Mn
Mar 31, 2025 186.47 Mn
Dec 31, 2024 198.65 Mn
Sep 30, 2024 220.40 Mn
Jun 30, 2024 178.14 Mn
Mar 31, 2024 65.91 Mn
Dec 31, 2023 68.79 Mn
Sep 30, 2023 67.34 Mn
Jun 30, 2023 70.78 Mn
Mar 31, 2023 72.98 Mn
Dec 31, 2022 74.18 Mn
Sep 30, 2022 86.52 Mn
Jun 30, 2022 90.95 Mn
Mar 31, 2022 96.92 Mn
Dec 31, 2021 123.93 Mn
Sep 30, 2021 141.81 Mn
API Access

BridgeBio Pharma Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=BBIO&period=max&api_key=YOUR_API_KEY